Literature DB >> 23042434

Epidemiology and mortality in dialysis patients with and without polycystic kidney disease: a national study in Taiwan.

Pei-Wen Lee1, Chih-Chiang Chien, Wu-Chang Yang, Jhi-Joung Wang, Chih-Ching Lin.   

Abstract

BACKGROUND: Polycystic kidney disease (PCKD) is one of the most common inherited disorders in end-stage renal disease patients. It is generally thought that the survival of PCKD patients undergoing dialysis surpasses that of general dialysis patients, but the cause of this improved survival is not clear.
METHODS: Using Taiwan's national health insurance claims data, we performed a longitudinal cohort study to investigate the survival and impact of comorbidities on mortality in dialysis patients with and without PCKD. We excluded patients without diabetes mellitus (DM) in a further analysis. A Cox proportional hazards model was used to identify the risk factors for all-cause mortality. The Kaplan-Meier method was used to describe overall patient survival.
RESULTS: Five hundred and one (2.25%) of 22,298 nondiabetic incident dialysis patients had PCKD. We found no significant difference in survival rates between those with and without PCKD. Being male, being over 65 years old and having congestive heart failure or cerebrovascular accident were each found to be independent predictors of mortality in the PCKD dialysis patients.
CONCLUSIONS: Taiwan has a lower incidence rate of PCKD than Western countries. In Taiwan, there is little difference in the long-term survival between dialysis patients with and without PCKD.

Entities:  

Mesh:

Year:  2012        PMID: 23042434     DOI: 10.5301/jn.5000224

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  8 in total

1.  PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan.

Authors:  Chih-Chuan Yu; An-Fu Lee; Stefen Kohl; Ming-Yen Lin; Siao Muk Cheng; Chi-Chih Hung; Jer-Ming Chang; Yi-Wen Chiu; Shang-Jyh Hwang; Edgar A Otto; Friedhelm Hildebrandt; Daw-Yang Hwang
Journal:  NPJ Genom Med       Date:  2022-07-01       Impact factor: 6.083

2.  Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry.

Authors:  Víctor Martínez; Jordi Comas; Emma Arcos; Joan Manel Díaz; Salomé Muray; Juan Cabezuelo; José Ballarín; Elisabet Ars; Roser Torra
Journal:  BMC Nephrol       Date:  2013-09-05       Impact factor: 2.388

3.  Risk of aortic aneurysm and dissection in patients with autosomal-dominant polycystic kidney disease: a nationwide population-based cohort study.

Authors:  Pei-Hsun Sung; Yao-Hsu Yang; Hsin-Ju Chiang; John Y Chiang; Chi-Jen Chen; Chien-Ting Liu; Cheuk-Man Yu; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-03-17

4.  Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014).

Authors:  Mangalee R Fernando; Hannah Dent; Stephen P McDonald; Gopala K Rangan
Journal:  Popul Health Metr       Date:  2017-02-17

5.  Prognosis of Vascular Access in Haemodialysis Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Tsung-Lun Lee; Chun-Fan Chen; Ann Charis Tan; Chia-Hao Chan; Shuo-Ming Ou; Fan-Yu Chen; Ko-Wen Yu; Yung-Tai Chen; Chih-Ching Lin
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

6.  Comparative Study of Outcomes among Patients with Polycystic Kidney Disease on Hemodialysis and Peritoneal Dialysis.

Authors:  Ju-Yeh Yang; Likwang Chen; Chia-Ter Chao; Yu-Sen Peng; Chih-Kang Chiang; Tze-Wah Kao; Kuo-Liong Chien; Hon-Yen Wu; Jenq-Wen Huang; Kuan-Yu Hung
Journal:  Sci Rep       Date:  2015-08-06       Impact factor: 4.379

7.  Epidemiology and mortality of liver abscess in end-stage renal disease dialysis patients: Taiwan national cohort study.

Authors:  Chon-Seng Hong; Kun-Ming Chung; Po-Chang Huang; Jhi-Joung Wang; Chun-Ming Yang; Chin-Chen Chu; Chung-Ching Chio; Fu-Lin Chang; Chih-Chiang Chien
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

8.  The Risk of Adverse Events in Patients With Polycystic Kidney Disease With Advanced Chronic Kidney Disease.

Authors:  Sonali de Chickera; Ayub Akbari; Adeera Levin; Mila Tang; Pierre Brown; Ognjenka Djurdev; Mohan Biyani; Edward G Clark; Manish M Sood
Journal:  Can J Kidney Health Dis       Date:  2018-06-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.